EX-10.2
Licensing Agreement dated Novemeber 10, 1998
122
EXHIBIT 10.2
This Agreement is given on the 10thday of November 1998
BETWEEN
EHPC IONISATION LIMITED a company incorporated under the laws of England and
Wales under company number 03541625 whose registered offices are located at 00x
Xxxxxxxxx Xxxxxxxx, Xxxxxx xx0 0XX (t Hereinafter known as the Licensor) AND
(1) XXXXXXX AND XXXXXXX LIMETED a company incorporated under the laws of England
and Wales under company number 021 2577 whose registered offices are located at
Xxxxxx Xxxxx, Xxxxxx Xxxx, Xxxxxxxxx, Xxxx TN 11 0QL (Hereinafter known as the
Licensee) (2) USF LIMITED a company incorporated under the laws of England and
Wales under company number 426414 whose registered offices are located at
Xxxxxxx Road, Xxxx Stoke on Trent, Staffs ST3 7020
1. The Parties agree to develop the Ionisation Non Halogen Disinfecting
system in accordance with the Development Programme.
2. a) EHPCI agrees to provide to USF for the purposes of the Development
Programme and to the extent the Parties agree is necessary, the
research services of Major Xxxxx Xxxx at EHPCI's facility xx Xxxxx
House, 0 Xxxxxxx Xxxx, Xxxxxxx. Xxxxxxxxx, Xxxxxx 0X00 S.HF and also at
a place or places to be nominated by USF for the purposes of the
Development.
b)USF shall pay t0 EHPCI a Research and Development Fee of(pound)30,000
at(pound)10,000 per month.
3. Each Party shall fund its participation in the development of the
ionisation Non Halogen Disinfecting System.
4. The period for the carrying out of the Development Programme shall
commence on the date of signature of this Agreement and expire three
months later or on such other date as the Parties agree to in
writing, which period is whereinafter called the "Development Period".
5. The Parties will meet at the following times:
a) every month during the duration of the Development Period
in order to discuss and evaluate the progress of the Development
Technology Know-how. EHPCI shall have the right to request additional
meetings upon reasonable notice to USF;
b) within thirty (30) days of the expiry of the Development
Period and determine the success or failure of the Development
Programme.
6. Neither Party will make any use of the disclosure of the Development
Programme Technology Know-How without the written consent of the
other.
7. The Parties agree that in the event of termination of this Agreement,
EHPCI shall have the right to Purchase the Development Programme
Technology Know-how from USF for a reasonable sum subject to a maximum
(pound)30.000 including those parts of the Development programme
Technology Know-how which are created by USF and those parts which
are not dependent on the Technology Know-How end to exploit the
Development Programme Technology Know-How at its absolute discretion.
123
8. The Parties further agree that USF shall, for their own benefit use,
the Anodes In respect of the Product arid the Development Programme
Technology Know-How Development
9. IMPROVEMENTS
9.1 During the Term:
a) EHPCI will disclose to USF Improvements made by EHPCI which
upon disclosure will be deemed to form part of the Technology
Know-How and subject to the Licence, and by USF will disclose
to EHPCI Improvements made by USF and apply the same to the
prosecution of the Licence. USF hereby grants EHPCI on
Exclusive licence to use such Improvements in its course of
business.
b) USF acknowledges and agrees that the Improvements described
in clause 9.1a and Intellectual Property rights subsisting
therein vest in EHPCI and Mat upon termination of this
Agreement by EHPCI in any event, may be exploited by EHPCI
alone or with third parties in such ways as EHPCI deems tit
without account to USF.
EXECUTED BY THE PARTIES IN THIS AGREEMENT
Signed for and on behalf of:
EHPCI LTD
USF LIMITED
124
